Mary Jeanne Milosevich, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 68845 Perez Rd, Ste H-6, Cathedral City, CA 92234 Phone: 760-328-0292 Fax: 760-328-9563 |
Karen Ann Smith Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 67425 Ovante Rd, Cathedral City, CA 92234 Phone: 760-409-2261 |
Enid M Weissman Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35825 Ottawa St, Cathedral City, CA 92234 Phone: 760-774-0725 Fax: 760-328-1432 |
Tracy Witty, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 69472 Serenity Rd, Cathedral City, CA 92234 Phone: 760-409-6383 Fax: 855-586-3292 |
Sandra L Avina, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 69472 Serenity Rd, Cathedral City, CA 92234 Phone: 760-409-6383 Fax: 866-225-9947 |
Wayne Hilty, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 69472 Serenity Rd, Cathedral City, CA 92234 Phone: 760-409-6383 Fax: 866-225-9947 |
News Archive
SeroVital®-hgh, the "Fountain of Youth" Formula everyone's talking about, has been making headlines ever since a group of some of the most renowned researchers in the world revealed that this oral compound is actually capable of increasing mean, endogenous, serum (blood) human growth hormone (hGH) levels by 682%. Experts everywhere — from dermatologists and obesity researchers to women's healthcare providers and even the famed Dr. Oz himself — began paying attention to this groundbreaking formula.
Eastern Long Island Hospital (ELIH) is among the top 15 percent in the nation for patient experience based on an analysis of patient surveys from 3,775 hospitals across the country by HealthGrades, the leading independent healthcare ratings organization. By placing in the top 15 percent, ELIH received the 2010/2011 HealthGrades Outstanding Patient Experience Award(TM).
Teleflex Incorporated, a leading global provider of medical technology products, today announced that it has entered into a definitive agreement to sell the Actuation business of its subsidiary Telair International Incorporated to TransDigm Group, Incorporated (NYSE: TDG) for approximately $94 million. The transaction is subject to receipt of Hart-Scott-Rodino approval and other customary closing conditions and is expected to close by the end of 2010.
Common cholesterol-lowering drugs could provide relief to patients suffering from a chronic lung disease, a study has shown.
Cancer patients with blood clots - which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients - gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented today at the 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer.
› Verified 3 days ago